Title: Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study | The British Journal of Psychiatry | Cambridge Core
ADHD is a neurodevelopmental disorder affecting attention and impulse control, often persisting into adulthood for about 90% of diagnosed children.
The global prevalence of adult ADHD is estimated at 2.8%, yet many adults in the UK remain undiagnosed and unsupported.
Individuals with ADHD face significant social and economic challenges, including educational underachievement, unemployment, and increased risk of substance abuse and mental health issues.
Adults diagnosed with ADHD have a higher likelihood of experiencing various health problems, including cardiovascular diseases and mental health disorders, as well as a greater risk of suicide.
A meta-analysis indicates that individuals with ADHD are twice as likely to die prematurely compared to the general population.
The study estimated that adults with ADHD in the UK experience a loss of approximately 6.78 years of life for males and 8.64 years for females compared to their non-ADHD counterparts.
The research utilized a matched cohort study design, analyzing data from UK electronic health records to assess mortality and life expectancy.
Adults with ADHD often have comorbid conditions that complicate their health outcomes, leading to increased mortality rates.
The findings emphasize the urgent need for improved support services and interventions for adults with ADHD to address their unmet health needs and reduce health disparities.
The study calls for policy initiatives similar to those addressing the life expectancy of autistic individuals, highlighting the necessity for targeted support for adults with ADHD to mitigate the risks associated with the disorder.